These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6169652)

  • 1. Controlled studies of intranasal immunotherapy for ragweed pollenosis.
    Mathews KP; Bayne NK; Banas JM; McLean JA; Bacon J
    Int Arch Allergy Appl Immunol; 1981; 66(2):218-24. PubMed ID: 6169652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local intranasal immunotherapy with high-dose polymerized ragweed extract.
    Georgitis JW; Nickelsen JA; Wypych JI; Barde SH; Clayton WF; Reisman RE
    Int Arch Allergy Appl Immunol; 1986; 81(2):170-3. PubMed ID: 3759259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and activity of polymerized ragweed: a double-blind, placebo-controlled trial in 81 patients with ragweed rhinitis.
    Grammer LC; Shaughnessy MA; Bernhard MI; Finkle SM; Pyle HR; Silvestri L; Patterson R
    J Allergy Clin Immunol; 1987 Aug; 80(2):177-83. PubMed ID: 3301986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local intranasal immunotherapy for ragweed allergic rhinitis. I. Clinical response.
    Nickelsen JA; Goldstein S; Mueller U; Wypych J; Reisman RE; Arbesman CE
    J Allergy Clin Immunol; 1981 Jul; 68(1):33-40. PubMed ID: 7240598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local intranasal immunotherapy for ragweed allergic rhinitis. II. Immunologic response.
    Nickelsen JA; Goldstein S; Mueller U; Wypych J; Reisman RE; Arbesman CE
    J Allergy Clin Immunol; 1981 Jul; 68(1):41-5. PubMed ID: 6972401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind study of the discontinuation of ragweed immunotherapy.
    Naclerio RM; Proud D; Moylan B; Balcer S; Freidhoff L; Kagey-Sobotka A; Lichtenstein LM; Creticos PS; Hamilton RG; Norman PS
    J Allergy Clin Immunol; 1997 Sep; 100(3):293-300. PubMed ID: 9314339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled trial of polymerized whole ragweed for immunotherapy of ragweed allergy.
    Grammer LC; Zeiss CR; Suszko IM; Shaughnessy MA; Patterson R
    J Allergy Clin Immunol; 1982 Jun; 69(6):494-9. PubMed ID: 7042799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen-controlled study of intranasal immunotherapy for ragweed hay fever.
    Welsh PW; Butterfield JH; Yunginger JW; Agarwal MK; Gleich GJ
    J Allergy Clin Immunol; 1983 May; 71(5):454-60. PubMed ID: 6601670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local nasal immunotherapy for ragweed-allergic rhinitis. III. A second year of treatment.
    Nickelsen JA; Georgitis JW; Mueller UR; Kane J; Wypych JI; Goldstein S; Reisman RE; Arbesman CE
    Clin Allergy; 1983 Nov; 13(6):509-19. PubMed ID: 6640886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma as a variable in a study of immunotherapy for allergic rhinitis.
    Grammer LC; Shaughnessey MA; Shaughnessy JJ; Patterson R
    J Allergy Clin Immunol; 1984 May; 73(5 Pt 1):557-60. PubMed ID: 6715723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.
    Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D;
    N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever.
    Norman PS; Lichtenstein LM; Kagey-Sobotka A; Marsh DG
    J Allergy Clin Immunol; 1982 Oct; 70(4):248-60. PubMed ID: 6181113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local intranasal immunotherapy for grass-allergic rhinitis.
    Georgitis JW; Reisman RE; Clayton WF; Mueller UR; Wypych JI; Arbesman CE
    J Allergy Clin Immunol; 1983 Jan; 71(1 Pt 1):71-6. PubMed ID: 6337198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen.
    Skoner D; Gentile D; Bush R; Fasano MB; McLaughlin A; Esch RE
    J Allergy Clin Immunol; 2010 Mar; 125(3):660-6, 666.e1-666.e4. PubMed ID: 20153030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever.
    Van Metre TE; Adkinson NF; Lichtenstein LM; Mardiney MR; Norman PS; Rosenberg GL; Sobotka AK; Valentine MD
    J Allergy Clin Immunol; 1980 Apr; 65(4):288-97. PubMed ID: 6987291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preseasonal intranasal immunotherapy with nebulized short ragweed extract.
    Welsh PW; Zimmermann EM; Yunginger JW; Kern EB; Gleich GJ
    J Allergy Clin Immunol; 1981 Mar; 67(3):237-42. PubMed ID: 7007474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.
    Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):132-8. PubMed ID: 8760779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of oral immunotherapy with short ragweed extract.
    Van Deusen MA; Angelini BL; Cordoro KM; Seiler BA; Wood L; Skoner DP
    Ann Allergy Asthma Immunol; 1997 Jun; 78(6):573-80. PubMed ID: 9207721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA and IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of histamine release.
    Platts-Mills TA; von Maur RK; Ishizaka K; Norman PS; Lichtenstein LM
    J Clin Invest; 1976 Apr; 57(4):1041-50. PubMed ID: 59737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.